Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alistair Brown is active.

Publication


Featured researches published by Alistair Brown.


Journal of Medicinal Chemistry | 2016

Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria

Sanjib Bhakta; Nicolò Scalacci; Arundhati Maitra; Alistair Brown; Saiprasad Dasugari; Dimitrios Evangelopoulos; Timothy D. McHugh; Parisa Nakhostin Mortazavi; Alexander Twist; Elena Petricci; Fabrizio Manetti; Daniele Castagnolo

Novel pyrroles have been designed, synthesized, and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the antitubercular drugs BM212 (1) and SQ109 (2), which showed common chemical features with very similar topological distribution. A perfect superposition of the structures of 1 and 2 revealed by computational studies suggested the introduction of bulky substituents at the terminal portion of the pyrrole C3 side chain and the removal of the C5 aryl moiety. Five compounds showed high activity toward Mycobacterium tuberculosis, while 9b and 9c were highly active also against multidrug-resistant clinical isolates. Compound 9c showed low eukaryotic cell toxicity, turning out to be an excellent lead candidate for preclinical trials. In addition, four compounds showed potent inhibition (comparable to that of verapamil) toward the whole-cell drug efflux pump activity of mycobacteria, thus turning out to be promising multidrug-resistance-reversing agents.


European Journal of Medicinal Chemistry | 2017

Synthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis.

Nicolò Scalacci; Alistair Brown; Fernando Rogério Pavan; Camila Maríngolo Ribeiro; Fabrizio Manetti; Sanjib Bhakta; Arundhati Maitra; Darren Smith; Elena Petricci; Daniele Castagnolo

The neuroleptic drug thioridazine has been recently repositioned as possible anti-tubercular drug. Thioridazine showed anti-tubercular activity against drug resistant mycobacteria but it is endowed with adverse side effects. A small library of thioridazine derivatives has been designed through the replacement of the piperidine and phenothiazine moieties, with the aim to improve the anti-tubercular activity and to reduce the cytotoxic effects. Among the resulting compounds, the indole derivative 12e showed an antimycobacterial activity significantly better than thioridazine and a cytotoxicity 15-fold lower.


Scientific Reports | 2017

Shigatoxin encoding Bacteriophage ϕ24B modulates bacterial metabolism to raise antimicrobial tolerance.

Giles Holt; John Lodge; Alan J. McCarthy; A. K. Graham; Gregory Young; Simon Bridge; Alistair Brown; Marta Veses-Garcia; Clare Lanyon; A. Sails; Heather E. Allison; Darren Smith

How temperate bacteriophages play a role in microbial infection and disease progression is not fully understood. They do this in part by carrying genes that promote positive evolutionary selection for the lysogen. Using Biolog phenotype microarrays and comparative metabolite profiling we demonstrate the impact of the well-characterised Shiga toxin-prophage ϕ24B on its Escherichia coli host MC1061. As a lysogen, the prophage alters the bacterial physiology by increasing the rates of respiration and cell proliferation. This is the first reported study detailing phage-mediated control of the E. coli biotin and fatty acid synthesis that is rate limiting to cell growth. Through ϕ24B conversion the lysogen also gains increased antimicrobial tolerance to chloroxylenol and 8-hydroxyquinoline. Distinct metabolite profiles discriminate between MC1061 and the ϕ24B lysogen in standard culture, and when treated with 2 antimicrobials. This is also the first reported use of metabolite profiling to characterise the physiological impact of lysogeny under antimicrobial pressure. We propose that temperate phages do not need to carry antimicrobial resistance genes to play a significant role in tolerance to antimicrobials.


Poetics Today | 2015

Communication Technology and Narrative: Letters, Instant Messaging, and Mobile Phones in Three Romantic Novels

Alistair Brown

Subscriptions Direct all orders to Duke University Press, Journals Customer Relations 905 W. Main St., Suite 18B, Durham, NC 27701. Annual subscription rates: print-plus-electronic institutions,


Archive | 2018

Is posthuman incest possible

Alistair Brown

426; print-only institutions,


Archive | 2016

Bacteriophage ɸ24B modulates microbial physiology and antimicrobial tolerance by hijacking the fatty acid synthesis pathway

Giles Holt; Alan J. McCarthy; John Lodge; Alistair Brown; Clare Lanyon; Heather E. Allison; Darren Smith

400; e-only institutions,


Archive | 2014

Stx-phage vB_EcoP 24B sculpting host bacterial function

Giles Holt; Heather E. Allison; S. Kinghan; Alan J. McCarthy; John Lodge; Alistair Brown; Clare Lanyon; Darren Smith

338; individuals,


Alluvium: 21st-Century Writing, 21st-Century Approaches | 2013

Are Video Game Narratives Postmodern

Alistair Brown

40; students,


Archive | 2012

Proving dissemination is only one half of your impact story: Twitter provides proof of real-time engagement with the public

Alistair Brown

20. For information on subscriptions to the e-Duke Journals Scholarly Collections, contact [email protected]. Print subscriptions: add


Alluvium: 21st-Century Writing, 21st-Century Approaches | 2012

Ulysses as an RPG

Alistair Brown

14 postage and applicable HST (including 5% GST) for Canada; add

Collaboration


Dive into the Alistair Brown's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giles Holt

Northumbria University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge